Strategy of TB Control in Migrating Population

  • Hong-yun Guan
  • Sheng-yuan Liu
  • Yu-zheng Fan
  • Wei-guo Tan
  • Wei-ye Yu


In the middle of the twentieth century, along with application of anti-tuberculosis drugs and implementation of DOTS strategy, the epidemic of TB has been sharply decreased worldwide. However, TB control has been a severe problem. In the year 2017, the new cases of TB amounted up to 10 million and the death cases of TB amounted up to 1.3 million. TB has been ranked as the 10th top killer in the world (World Health Organization. Global tuberculosis report 2018. World Health Organization, Geneva, 2018). Studies have demonstrated that with rapid economic development and more frequent interpersonal communications, the opportunities of business travelling, tourism, migrating, and labor service have been increasing. The consequent flow of population presents great challenge to TB control worldwide. The large-scale flow of population during the economic transition in China may aggravate the epidemic of TB. The large migrating population consists of mainly young and middle-aged individuals from the rural areas of China. It is a population vulnerable to TB infection due to their low income, poor housing conditions, low level of education, insufficient knowledge about prevention of TB, and insufficient coverage by the National Health-care Formulary in China. In addition, patients with TB in migrating population are more commonly subject to delayed diagnosis and treatment. TB control in migrating population has been one of the focused problems in TB control in China.


  1. 1.
    World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018.Google Scholar
  2. 2.
    Styblo K. Dr. Karel Styblo symposium: an emerging global programme against tuberculosis. The Hague, March 15, 1991. Bull Int Union Tuberc Lung Dis. 1991;66(4):139–214.Google Scholar
  3. 3.
    World Health Organization. Forty-fourth world health assembly, resolutions and decisions. Geneva: World Health Organization; 1991.Google Scholar
  4. 4.
    Wang LX, Jiang SW. Development and prospects of the national TB control strategy in China. Chin J Anti-tuberc. 2014;36(8):630–3.Google Scholar
  5. 5.
    Frieden TR, Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clin Chest Med. 2005;26(2):197–205.PubMedGoogle Scholar
  6. 6.
    Nie WJ, Chu NH. The 7th interpretation about the partner handbook of the guideline for drug-resistant TB planning management issued by WHO in 2014: treatment of multidrug-resistant TB and extensive drug-resistant TB. Chin J Anti-tuberc. 2015;37(7):800–2.Google Scholar
  7. 7.
    Shen XMJ, Gao Q. DOTS-Plus: a powerful weapon for control of multidrug-resistant tuberculosis. J Shanghai Prevent Med. 2006;18(5):225–6.Google Scholar
  8. 8.
    World Health Organization. The stop TB strategy, building on and enhancing DOTS to meet the TB-related millennium development goals. Geneva: World Health Organization; 2006.Google Scholar
  9. 9.
    Liu JJ. Strategies for tuberculosis control. Health Edu Tuberc Control. 2006;1:11–5.Google Scholar
  10. 10.
    Dai BZ, Zhan SK. TB control and its strategy in migrating population. J Shanghai Prevent Med. 2005;17(3):111–2.Google Scholar
  11. 11.
    Population Division, Department of Economic and Social Affairs, the United Nations. Trends in international migrant stock: the 2008 revision. p. 1–2.Google Scholar
  12. 12.
    Dye C, Lönnroth K, Jaramillo E, et al. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ. 2009;87(9):683–91.PubMedPubMedCentralGoogle Scholar
  13. 13.
    U.S. Department of Health and Human Services. Centers for disease control and prevention, trends in tuberculosis—United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(11):333–7.Google Scholar
  14. 14.
    Menzies HJ, Winston CA, Holtz TH, et al. Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994-2007. Am J Public Health. 2010;100(9):1724–9.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Win KMK, Chee CBE, Shen L, et al. Tuberculosis among foreign-born persons, Singapore, 2000-2009. Emerg Infect Dis. 2011;17(3):517–9.PubMedCentralGoogle Scholar
  16. 16.
    Borrell S, Espanol M, Orcau A, et al. Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona. Clin Microbiol Infect. 2010;16(6):568–74.PubMedGoogle Scholar
  17. 17.
    Salinas JL, Mindra G, Haddad MB, et al. Leveling of tuberculosis incidence United States, 2013-2015. MMWR Morb Moral Wkly Rep. 2016;65(11):273–8.Google Scholar
  18. 18.
    Ho MJ. Migratory journeys and tuberculosis risk. Med Anthropol Q. 2003;17(4):442–58.PubMedGoogle Scholar
  19. 19.
    Bao J. Prevalence of TB and its control strategy in the US. Chin J Anti-tuberc. 2017;39(2):198–201.Google Scholar
  20. 20.
    Centers for Disease Control and Prevention. National TB program objectives and performance targets for 2020. [2016-11-16].
  21. 21.
    Raviglione MC, Sudre P, Rieder HL, et al. Secular trends of tuberculosis in Western Europe. Bull World Health Organ. 1993;71(3/4):297–306.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Inigo J, Arce A, Rodriguez E, et al. Tuberculosis trends in Madrid, 1994-2003: impact of immigration and HIV infection. Int J Tuberc Lung Dis. 2006;10(5):550–3.PubMedGoogle Scholar
  23. 23.
    Marks GB, Bai J, Stewart GJ, et al. Effectiveness of post-migration screening in controlling tuberculosis among refugees: a historical cohort study, 1984-1998. Am J Public Health. 2001;91(11):1797–9.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Suarez PG, Watt CJ, Alarcon E, et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis. 2001;184(4):473–8.PubMedGoogle Scholar
  25. 25.
    Frieden TR. Can tuberculosis be controlled? Int J Epidemiol. 2002;31(5):894–9.PubMedGoogle Scholar
  26. 26.
    Baltussen R, Floyd K, Dye C. Cost-effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ. 2005;331(7529):1364.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Pantoja A, Lonnroth K, Lal SS, et al. Economic evaluation of Public-private mix for tuberculosis care and control. India, part II. Cost and cost-effectiveness. Int J Tuberc Lung Dis. 2009;13(6):705–12.PubMedGoogle Scholar
  28. 28.
    Zhong Q, Yang YZ. Implementation and prospects of DOTS strategy in TB patients from migrating population in Shenzhen. Chin J Anti-tuberc. 1998;20(2):61–4.Google Scholar
  29. 29.
    Tan WG, Wu QF, Yang YZ. Analysis of TB control in migrating population of Shenzhen [J]. Chin J Anti-tuberc. 2001;23(2):99–102.Google Scholar
  30. 30.
    Wei GF, Zhang YR. Analysis of TB control in migrating population in Shijingshan district of Beijing. J Clin Pneumol. 2002;7(1):33–4.Google Scholar
  31. 31.
    Chen YW, Zhang ZP. Management of TB patients in migrating population in Yin county of Zhengjiang province. Zhejiang Prevent Med. 2000;12(10):23–4.Google Scholar
  32. 32.
    Jiang SW, Wang J, Liu XQ, et al. Development of TB control in migrating population of China. Chin J Anti-tuberc. 2008;30(SI):7–9.Google Scholar
  33. 33.
    Huang JY, Xie QH. Cultural construction at China-ASEAN land border ports. Guangxi Soc Sci. 2018;6:87–9.Google Scholar
  34. 34.
    Li H, Hou RS, Wang JJ, et al. Surveillance of infectious diseases in entry-exit population at the ports in Henan province: data analysis during 2005 to 2014. Port Health Control. 2015;21(4):5–9.Google Scholar
  35. 35.
    Ma S, Chen P, Yang B, et al. Detection of communicable tuberculosis in entry-exit population at the ports in Shandong province: descriptive data, epidemiological analysis and its control strategy. Port Health Control. 2012;4:37–42.Google Scholar
  36. 36.
    Chen L, Wang C, Chen F. Surveillance of diseases in entry-exit population at the ports in Yangzhou: data analysis during 2011-2016. Port Health Control. 2017;22(4):37–9.Google Scholar
  37. 37.
    Wang J, Zhang Q, Fang Y. Surveillance of imported tuberculosis at the ports in Shanghai: data analysis during 2009-2015. J Tuberc Pulm Health. 2016;5(3):222–6.Google Scholar
  38. 38.
    Aldridge RW, Yates TA, Zenner D, et al. Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(12):1240–9.PubMedGoogle Scholar
  39. 39.
    King K, Douglas PJ, Beath K. Is premigration health screening for tuberculosis worthwhile. Med J Aust. 2011;195(9):534–7.PubMedGoogle Scholar
  40. 40.
    An H, J B, Kg C. Modelling tuberculosis trends in the USA. Epidemiol Infect. 2012;10(140):1862–72.Google Scholar
  41. 41.
    Baker BJ, Winston CA, Liu Y, et al. Abrupt decline in tuberculosis among foreign-born persons in the United States. PLoS ONE. 2016;11(2):e147353.Google Scholar
  42. 42.
    Verhagen LM, van den Hof S, van Deutekom H, et al. Mycobacterial factors relevant for transmission of tuberculosis. J Infect Dis. 2011;203(9):1249–55.PubMedGoogle Scholar
  43. 43.
    Klinkenberg E, Manissero D, Semenza JC, et al. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J. 2009;34(5):1180–9.PubMedGoogle Scholar
  44. 44.
    Pareek M, Baussano I, Abubakar I, et al. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis. 2012;18(9):1422–9.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Meng CY, Zhou X, Cai L, et al. Tuberculosis screening strategy and result in exit population to five countries at the ports of Shanghai. Chin J Front Health Insp. 2016;5:352–5.Google Scholar
  46. 46.
    Fan XJ, Sun M. Laboratory diagnosis of tuberculosis: a comparative study. Chin J Front Health Insp. 2005;3:160–2.Google Scholar
  47. 47.
    Ruan C. Surveillance and management of infectious diseases in entry-exit population. Ningbo: Ningbo University; 2017.Google Scholar
  48. 48.
    Yang HL, Li L, Wang YL, et al. Problems in surveillance and management of tuberculosis in entry-exit population and the solutions. J Insp Quar. 2016;2:62–4.Google Scholar
  49. 49.
    Yang YZ, Tan WG, Luo YX, et al. Implementation of TB control in migrating population. Chin J Publ Health Manage. 1999;15(2):80–2.Google Scholar
  50. 50.
    Guan HY, Tan WG, Yang YZ, et al. Comprehensive management of trans-regional flowing TB patients in Shenzhen. Chin J Anti-tuberc. 2015;37(5):498–503.Google Scholar
  51. 51.
    Guan HY, Tan WG, Yang YZ, et al. Epidemiological analysis of TB epidemic in students of Shenzhen from 2009 to 2013. J Clin Pneumol. 2016;21(8):1496–9.Google Scholar
  52. 52.
    Wu QF, Yang YZ, Xu L, et al. Analysis of TB epidemic in Shenzhen based on data of reporting and registry in 2006-2010. Guangdong Med. 2011;32(17):2309–10.Google Scholar
  53. 53.
    Wu QF, Tan WG, Yang YZ, et al. Surveillance on drug resistance of mycobacteria tuberculosis in Shenzhen during. J Clin Pneumol. 2010;15(8):1121–3.Google Scholar
  54. 54.
    Lu CR, Tan WG, Zhuo ZP, et al. Epidemic of isoniazid resistant and rifampicin resistant TB in Shenzhen during 1999 to 2015. Electron J Emerg Inf Dis. 2017;2(1):10–3.Google Scholar
  55. 55.
    Wu QF, Tan WG, Luo DQ, et al. TB control in prisons of Shenzhen and its effects. J Clin Pneumol. 2015;20(9):1571–4.Google Scholar
  56. 56.
    Guan HY, Yang YZ, Tan WG, et al. Referral and tracing of suspected cases of TB reported by health-care institutions in Shenzhen in 2011-2016. Chin J Trop Med. 2017;17(8):766–9.Google Scholar
  57. 57.
    Wu QF, Tan WG, Lv DL, et al. Referral and tracing of suspected cases of TB in Shenzhen. Chin J Trop Med. 2013;13(8):984–6.Google Scholar
  58. 58.
    Guan HY, Yang YZ, Tan WG, et al. Performance assessment of the Tuberculosis Control Planning in Shenzhen (2001-2010). Chin J Anti-tuberc. 2013;35(9):729–37.Google Scholar
  59. 59.
    Cheng JQ, Yang YZ, Zhang D, et al. Performance assessment of the World Bank loan for TB control program in Shenzhen. Chin J Public Health. 2004;20(7):73–5.Google Scholar
  60. 60.
    Wu QF, Xu JJ, Tan WG, et al. Health economical assessment on tuberculosis control in Shenzhen. Chin J Trop Med. 2006;6(5):775–6.Google Scholar
  61. 61.
    Guan HY, Tan WG, Yang YZ, et al. Management and treatment of patients with TB based on eDOT system. Chin J Anti-tuberc. 2017;39(7):702–7.Google Scholar
  62. 62.
    Guan HY, Tan WG, Yang YZ, et al. Detection, treatment and management of 652 cases of MDR-TB in Shenzhen in 2006-2014. Chin J Anti-tuberc. 2017;39(5):518–24.Google Scholar
  63. 63.
    Che XL, Wu QF, Lv DL, et al. Performance assessment of the global funding for MDR-TB control in Shenzhen. Chin J Trop Med. 2017;17(10):988–90.Google Scholar

Copyright information

© People's Medical Publishing House, PR of China 2020

Authors and Affiliations

  • Hong-yun Guan
    • 1
  • Sheng-yuan Liu
    • 1
  • Yu-zheng Fan
    • 1
  • Wei-guo Tan
    • 2
  • Wei-ye Yu
    • 2
  1. 1.Shenzhen Nanshan Center for Chronic Disease ControlShenzhenChina
  2. 2.Department of TuberculosisThe Shenzhen Center for Chronic Disease ControlShenzhenChina

Personalised recommendations